ARCHIVES

Four More Cooperative Groups Disapproved As NCI to Consider New Directions in Clinical Trials

This article is from The Cancer Letter archive.

Vol. 12 No. 13 | March 28, 1986

Download PDF Visit The Full Archive

Related Articles

Wittes, Fraumeni Appointed As Division Directors

February 9, 1996

Overdiagnosis Since Advent Of Prostate Cancer Screening

September 25, 2009

NIH Probing: Double Dipping” Allegation

September 4, 1981

DRCCA Board Votes To End Support For CCPDS July 31, 1983

May 14, 1982

In Brief: Reauthorization May Be Wrapped Up This Week As House, Senate Work Toward Compromise

October 14, 1988

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

March 26, 1993